PILL
Direxion Daily Phrmctcl&MdclBl3XShrsETF
NAV as of
4 Week: 7.70 - 9.39
52 Week: 4.80 - 9.82
Latest Closing Price
8.14
Premium / Discount
0.32
Expense Ratio
1.01%
Investment Objective
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Main Fund Characteristics
Performance
Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
---|---|---|---|
YTD | 5.03 | 3.20 | 1.57 |
1 Day | 5.71 | 0.00 | 0.00 |
1 Week | -0.73 | 7.87 | -0.09 |
1 Month | -16.17 | 13.06 | -1.24 |
3 Months | 3.30 | 25.03 | 0.13 |
6 Months | 11.05 | 39.40 | 0.28 |
1 Year | -3.78 | 48.79 | -0.08 |
2 Years | -44.32 | 85.75 | -0.52 |
3 Years | -62.56 | 102.85 | -0.61 |
5 Years | -64.26 | 151.57 | -0.42 |
10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -19.5739 | 18.2000 | -0.3394 | -37.1710 | -43.1017 | -12.6643 |
Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Dividend Frequency
Lastest Dividend
Ex Date | Payment Date | Dividend Payout per unit |
---|---|---|
N.A |
Portfolio Data
Total Number of Holdings: 45
Number of Bond Holdings: 0
Number of Equity Holdings: 42
Total Market Value: 15,672,357
Portfolio Composition
Top 10 Holdings
% Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
---|---|---|---|---|---|
1 | S&P Pharmaceuticals Select Index Swap | 8.9993 | 4,811 | 0 | 1,268,908 |
2 | Axsome Therapeutics Inc | 3.7337 | 6,862 | 0 | 526,453 |
3 | Merck & Co Inc | 3.6561 | 4,107 | 0 | 515,511 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
Size | % of portfolio |
---|---|
Giant | 10.82 |
Large | 10.43 |
Medium | 10.57 |
Small | 24.99 |
Micro | 20.93 |
Equity Style Box Breakdown
0 | 0 | 0 | Large |
0 | 0 | 0 | Mid |
0 | 0 | 0 | Small |
Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
10.3921
Price/Book*
2.5818
Price/Sales*
2.3411
Price/Cash Flow*
9.4839
Dividend Yield*
1.7576
Growth Measures
Long-Term Earnings
15.6460
Historical Earnings
-2.3205
Sales Growth
1.5232
Cash-Flow Growth
-8.5426
Book-Value Growth
0.9600
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
Detail | Value |
---|---|
Average Effective Duration | 0 |
Average Effective Maturity (Years)* | 0 |
Average Credit Quality | 0 |
Average Weighted Coupon* | 2.06 |
Average Weighted Price* | 0 |
Bond Style Box Breakdown
0 | 0 | 0 | High | Quality |
0 | 0 | 0 | Med | |
0 | 0 | 0 | Low | |
Ltd | Mod | Ext | ||
Interest-Rate Sensitivity |
Credit Quality
Type | % Bonds |
---|---|
N.A |
Bond Sector
Bond Maturity
% Bonds | |
---|---|
1 to 3 Years | 0.00 |
3 to 5 Years | 0.00 |
5 to 7 Years | 0.00 |
7 to 10 Years | 0.00 |
10 to 15 Years | 0.00 |
15 to 20 Years | 0.00 |
20 to 30 Years | 0.00 |
Over 30 Years | 5.78 |
1 to 7 Days | 0.00 |
8 to 30 Days | 0.00 |
31 to 90 Days | 0.00 |
91 to 182 Days | 0.00 |
183 to 364 Days | 0.00 |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.